1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Netherlands

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: Netherlands
NETHERLANDS 1
HEALTHCARE SYSTEM 1
Facts and Figures 1
Market Indicators 2
Provision and Funding 4
Basic Health Insurance 4
Supplementary Health Insurance 6
Long-term Care 6
Healthcare Funding 6
Healthcare Providers 7
PRICING 7
Prescription Drugs 7
WGP Methodology 7
WGP Price Revisions 8
Pricing Agreements 8
Generic Drugs 8
Hospital Drugs 8
Pricing Rules 8
Price Negotiations and Tendering 9
Controversy over Hospital Medicines Prices 9
Joint Purchasing Schemes 10
Cross-border Procurement 11
OTC Drugs 11
REIMBURSEMENT 12
Admission to Reimbursement 12
Pre-assessment Process 12
Reimbursement Applications 12
Assessment 13
Decision 15
Appeals 15
Simplified Reimbursement Process 15
Managed Entry Schemes 15
Provisional Reimbursement 19
Barriers to Access 19
Reimbursement Categories 20
Reimbursement Prices 21
Reference Price System 21
Preference Policy Scheme 21
Hospital Reimbursement 23
Automatic Reimbursement 23
Denial of Automatic Reimbursement 23
Reassessments 24
Managed Entry Schemes 24
Formularies 25
DRG System 26
Netherlands, Pharmaceutical Pricing and Reimbursement Concise Guide
v
DRG Add-on Drugs 26
Specialist Drugs for Hospital Out-patients 27
Changes in Reimbursement Status 28
Retail Sector 28
Hospital Sector 29
Changes in Reimbursement Prices 30
Maximum Prices 30
Reference Prices 30
Preference Policy 30
Price Re-negotiations 30
Impact of Price Controls 31
PHARMACOECONOMICS 31
Pharmacoeconomic Requirements 31
Mandatory Requirement 31
Exemptions 31
Pharmacoeconomic Guidelines 32
Proposed QALY Threshold 33
Hospital Drugs 33
Orphan Drugs 33
Provisional Reimbursement 34
PRICE BUILD UP 34
Wholesalers 34
Margins 34
Background 34
Retail Pharmacies 34
Pharmacy Remuneration 34
Discounts 35
Clawback System 35
Background 36
Pharmacy Chains 36
OTC Sales 36
E-pharmacy 36
Supply Shortages 37
Dispensing Doctors 37
Sales Tax 37
COST CONTAINMENT 37
Industry Paybacks 37
Promotional Costs 37
Patient Co-payments 38
Deductible 38
Other Charges for Prescription Medicines 38
Prescribing Controls 39
Treatment Guidelines 39
Targets 39
Analysis of Prescribing Habits 40
Other Prescribing Information 40
Electronic Prescribing Systems 41
Netherlands, Pharmaceutical Pricing and Reimbursement Concise Guide
vi
Managed Entry Schemes 41
Incentives 41
Generics 41
Market 41
INN Prescribing 41
Substitution 42
Preference Policy 42
Biosimilars 42
Rx-to-OTC Switches 43
Switching Process 43
OTC Market 43
Parallel Trade 43
FUTURE DEVELOPMENTS 44
Outlook 44
Drug Pricing 44
Medicines Policy Plan 44
Cross-border Co-operation 46
Cost-effectiveness Threshold 46
NAMES and ADDRESSES 46

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

US POC Ancillary Hospital Locations (ER, OR, ICU/CCU) Diagnostic Testing Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

2016 Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 973-page report contains 153 tables and provides a comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis ...

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.